Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q6079042> ?p ?o }
Showing triples 1 to 51 of
51
with 100 triples per page.
- Q6079042 subject Q16811554.
- Q6079042 subject Q7071513.
- Q6079042 subject Q8844484.
- Q6079042 subject Q8852204.
- Q6079042 subject Q9052323.
- Q6079042 abstract "Isavuconazole (BAL4815; trade name Cresemba) is a triazole antifungal drug. Its prodrug, isavuconazonium sulfate (BAL8557), was granted approval by the U.S. Food and Drug Administration (FDA) on March 6, 2015During its Phase III drug trials, Astellas partnered with Basilea Pharmaceutica, the developer of the drug, for rights to co-development and marketing of isavuconazole. On May 28, 2013, Basilea Pharmaceutica announced it had been granted orphan drug status by the FDA for treatment of aspergillosis. Since then, it has also been granted orphan drug status for the treatment of invasive candidiasis.".
- Q6079042 atcPrefix "J02".
- Q6079042 atcSuffix "AC05".
- Q6079042 chEBI "85979".
- Q6079042 fdaUniiCode "60UTO373KE".
- Q6079042 iupacName "4-{2-[(1R,2R)-(2,5-Difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-1,3-thiazol-4-yl}benzonitrile".
- Q6079042 pubchem "6918485".
- Q6079042 thumbnail Isavuconazole_structure.svg?width=300.
- Q6079042 wikiPageWikiLink Q12074763.
- Q6079042 wikiPageWikiLink Q1367466.
- Q6079042 wikiPageWikiLink Q143263.
- Q6079042 wikiPageWikiLink Q14864419.
- Q6079042 wikiPageWikiLink Q16811554.
- Q6079042 wikiPageWikiLink Q1805541.
- Q6079042 wikiPageWikiLink Q204711.
- Q6079042 wikiPageWikiLink Q259626.
- Q6079042 wikiPageWikiLink Q335130.
- Q6079042 wikiPageWikiLink Q412236.
- Q6079042 wikiPageWikiLink Q419639.
- Q6079042 wikiPageWikiLink Q528842.
- Q6079042 wikiPageWikiLink Q578726.
- Q6079042 wikiPageWikiLink Q603741.
- Q6079042 wikiPageWikiLink Q640448.
- Q6079042 wikiPageWikiLink Q6931254.
- Q6079042 wikiPageWikiLink Q7071513.
- Q6079042 wikiPageWikiLink Q7180990.
- Q6079042 wikiPageWikiLink Q810060.
- Q6079042 wikiPageWikiLink Q8844484.
- Q6079042 wikiPageWikiLink Q8852204.
- Q6079042 wikiPageWikiLink Q903341.
- Q6079042 wikiPageWikiLink Q9052323.
- Q6079042 wikiPageWikiLink Q906453.
- Q6079042 atcPrefix "J02".
- Q6079042 atcSuffix "AC05".
- Q6079042 chebi "85979".
- Q6079042 iupacName "4".
- Q6079042 pubchem "6918485".
- Q6079042 unii "60".
- Q6079042 type ChemicalSubstance.
- Q6079042 type Drug.
- Q6079042 type ChemicalObject.
- Q6079042 type Thing.
- Q6079042 type Q8386.
- Q6079042 comment "Isavuconazole (BAL4815; trade name Cresemba) is a triazole antifungal drug. Its prodrug, isavuconazonium sulfate (BAL8557), was granted approval by the U.S. Food and Drug Administration (FDA) on March 6, 2015During its Phase III drug trials, Astellas partnered with Basilea Pharmaceutica, the developer of the drug, for rights to co-development and marketing of isavuconazole.".
- Q6079042 label "Isavuconazole".
- Q6079042 depiction Isavuconazole_structure.svg.